Skip to main
G
G logo

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Genpact Ltd. is positioned for positive financial performance, as evidenced by projected low-double digit revenue growth, supported by strong bookings momentum leading to margin expansion and capital returns to shareholders through buybacks and dividends. The demand for the company’s core business process management (BPM) and analytics services is expected to improve, particularly as Global 2000 firms seek to streamline operations and reduce costs, which will likely accelerate growth. Additionally, management's revenue growth targets, complemented by a robust deal pipeline and increasing demand for AI-based solutions, indicate a favorable outlook for Genpact’s future performance once macroeconomic conditions stabilize.

Bears say

Genpact faces significant challenges related to employee retention in key regions, which could adversely affect its revenue growth. Additionally, economic shocks, such as those experienced during the Covid-19 pandemic, may hinder client decision-making processes and further impact revenue. Furthermore, unfavorable currency movements represent a potential risk to both Genpact's top and bottom lines, contributing to a negative outlook on the company's financial performance.

Genpact (G) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Buy based on their latest research and market trends.

According to 7 analysts, Genpact (G) has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.